Table of Contents

Global Drugs of Abuse Testing Market Size, Status and Forecast 2022
1 Industry Overview of Drugs of Abuse Testing
    1.1  Drugs of Abuse Testing Market Overview
        1.1.1 Drugs of Abuse Testing Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Drugs of Abuse Testing Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Drugs of Abuse Testing Market by Type
        1.3.1 Immunoassays Analyzers
        1.3.2 Chromatographic Devices
        1.3.3 Breath Analyzers
    1.4 Drugs of Abuse Testing Market by End Users/Application
        1.4.1 Urine Testing Devices
        1.4.2 Oral Fluid Testing Devices

2 Global Drugs of Abuse Testing Competition Analysis by Players
    2.1 Drugs of Abuse Testing Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Quest Diagnostics
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Drugs of Abuse Testing Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Laboratory Corporation of America Holdings
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Drugs of Abuse Testing Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Alere
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Drugs of Abuse Testing Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Roche Diagnostics
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Drugs of Abuse Testing Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Thermo Fisher Scientific
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Drugs of Abuse Testing Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Dr?gerwerk
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Drugs of Abuse Testing Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Siemens Healthcare
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Drugs of Abuse Testing Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Express Diagnostics
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Drugs of Abuse Testing Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Shimadzu
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Drugs of Abuse Testing Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 MPD
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Drugs of Abuse Testing Revenue (Value) (2012-2017)
        3.10.5 Recent Developments

4 Global Drugs of Abuse Testing Market Size by Type and Application (2012-2017)
    4.1 Global Drugs of Abuse Testing Market Size by Type (2012-2017)
    4.2 Global Drugs of Abuse Testing Market Size by Application (2012-2017)
    4.3 Potential Application of Drugs of Abuse Testing in Future
    4.4 Top Consumer/End Users of Drugs of Abuse Testing

5 United States Drugs of Abuse Testing Development Status and Outlook
    5.1 United States Drugs of Abuse Testing Market Size (2012-2017)
    5.2 United States Drugs of Abuse Testing Market Size and Market Share by Players (2016 and 2017)

6 EU Drugs of Abuse Testing Development Status and Outlook
    6.1 EU Drugs of Abuse Testing Market Size (2012-2017)
    6.2 EU Drugs of Abuse Testing Market Size and Market Share by Players (2016 and 2017)

7 Japan Drugs of Abuse Testing Development Status and Outlook
    7.1 Japan Drugs of Abuse Testing Market Size (2012-2017)
    7.2 Japan Drugs of Abuse Testing Market Size and Market Share by Players (2016 and 2017)

8 China Drugs of Abuse Testing Development Status and Outlook
    8.1 China Drugs of Abuse Testing Market Size (2012-2017)
    8.2 China Drugs of Abuse Testing Market Size and Market Share by Players (2016 and 2017)

9 India Drugs of Abuse Testing Development Status and Outlook
    9.1 India Drugs of Abuse Testing Market Size (2012-2017)
    9.2 India Drugs of Abuse Testing Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Drugs of Abuse Testing Development Status and Outlook
    10.1 Southeast Asia Drugs of Abuse Testing Market Size (2012-2017)
    10.2 Southeast Asia Drugs of Abuse Testing Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Drugs of Abuse Testing Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Drugs of Abuse Testing Revenue and Growth Rate (2017-2022)
        11.1.2 EU Drugs of Abuse Testing Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Drugs of Abuse Testing Revenue and Growth Rate (2017-2022)
        11.1.4 China Drugs of Abuse Testing Revenue and Growth Rate (2017-2022)
        11.1.5 India Drugs of Abuse Testing Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Drugs of Abuse Testing Revenue and Growth Rate (2017-2022)
    11.2 Global Drugs of Abuse Testing Market Size (Value) by Type (2017-2022)
    11.3 Global Drugs of Abuse Testing Market Size by Application (2017-2022)

12 Drugs of Abuse Testing Market Dynamics
    12.1 Drugs of Abuse Testing Market Opportunities
    12.2 Drugs of Abuse Testing Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Drugs of Abuse Testing Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Drugs of Abuse Testing Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source